Literature DB >> 9153522

Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy.

H Yamauchi1, H Fukuyama, Y Nagahama, Y Katsumi, Y Dong, J Konishi, J Kimura.   

Abstract

Recent studies disclosed neurofibrillary degeneration in layer 3 of the association cortex in patients with progressive supranuclear palsy. This lesion may be associated with corpus callosum atrophy and may impair the function of cortical regions indispensable for complex cognitive activity. To investigate whether corpus callosum atrophy is associated with cognitive impairment and cerebral cortical hypometabolism, we studied 10 patients with progressive supranuclear palsy using magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose as a tracer. Compared with 23 age-matched control subjects, the patients had significantly decreased callosal area-skull area ratios, with anterior predominance of the degree of atrophy. The corpus callosum atrophy was accompanied by a decreased mean cortical glucose metabolic rate, predominantly in the frontal region of the cortex, and poor performance on the picture arrangement subtest of the Wechsler Adult Intelligence Scale and the verbal fluency task. We conclude that corpus callosum atrophy with anterior predominance is present in progressive supranuclear palsy, and that this atrophy is associated with cognitive impairment and cerebral cortical hypometabolism, especially in the frontal cortical region. Corpus callosum atrophy may reflect the pathological changes in the cerebral cortex, accentuated in the frontal region, that contribute to the development of frontal lobe dysfunction in this disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153522     DOI: 10.1002/ana.410410509

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

Review 1.  Progressive supranuclear palsy.

Authors:  H U Rehman
Journal:  Postgrad Med J       Date:  2000-06       Impact factor: 2.401

2.  An electrophysiological investigation of interhemispheric transfer time in children and adolescents with high-functioning autism spectrum disorders.

Authors:  Ann Clawson; Peter E Clayson; Mikle South; Erin D Bigler; Michael J Larson
Journal:  J Autism Dev Disord       Date:  2015-02

3.  MRI Planimetry and Magnetic Resonance Parkinsonism Index in the Differential Diagnosis of Patients with Parkinsonism.

Authors:  V C Constantinides; G P Paraskevas; G Velonakis; P Toulas; E Stamboulis; E Kapaki
Journal:  AJNR Am J Neuroradiol       Date:  2018-04-05       Impact factor: 3.825

4.  Clinical correlates of white matter tract degeneration in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; Ankit V Master; Ramesh Avula; Kejal Kantarci; Scott D Eggers; Heidi A Edmonson; Clifford R Jack; Keith A Josephs
Journal:  Arch Neurol       Date:  2011-06

5.  Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases.

Authors:  H Yamauchi; H Fukuyama; Y Dong; H Nabatame; Y Nagahama; S Nishizawa; J Konishi; H Shio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

6.  Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer's disease.

Authors:  H Yamauchi; H Fukuyama; Y Nagahama; Y Katsumi; T Hayashi; C Oyanagi; J Konishi; H Shio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

Review 7.  Contribution of callosal connections to the interhemispheric integration of visuomotor and cognitive processes.

Authors:  Tilman Schulte; Eva M Müller-Oehring
Journal:  Neuropsychol Rev       Date:  2010-04-17       Impact factor: 7.444

8.  Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy.

Authors:  Shoichi Ito; Takahiro Makino; Wakako Shirai; Takamichi Hattori
Journal:  Neuroradiology       Date:  2008-09-09       Impact factor: 2.804

Review 9.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

10.  Role of Corpus Callosum Volumetry in Differentiating the Subtypes of Progressive Supranuclear Palsy and Early Parkinson's Disease.

Authors:  Abhishek Lenka; Shaik Afsar Pasha; Sandhya Mangalore; Lija George; Ketan Ramakant Jhunjhunwala; Bhawani Shankar Bagepally; Rajini M Naduthota; Jitender Saini; Ravi Yadav; Pramod Kumar Pal
Journal:  Mov Disord Clin Pract       Date:  2017-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.